Claes Lindblad
Finanzdirektor/CFO bei MODUS THERAPEUTICS HOLDING AB
Aktive Positionen von Claes Lindblad
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MODUS THERAPEUTICS HOLDING AB | Finanzdirektor/CFO | 15.03.2021 | - |
Karriereverlauf von Claes Lindblad
Ehemalige bekannte Positionen von Claes Lindblad
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OSSDSIGN AB | Finanzdirektor/CFO | 01.02.2016 | 01.01.2020 |
Unternehmenssekretär | 01.02.2016 | 01.01.2020 | |
ConvaTec (Sweden) AB | Direktor/Vorstandsmitglied | 01.07.2012 | 01.03.2016 |
Corporate Officer/Principal | 01.07.2012 | 01.03.2016 | |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Vertrieb & Marketing | 28.01.2010 | 01.07.2012 |
Ausbildung von Claes Lindblad
Karlstad University | Graduate Degree |
Edinburgh Business School | Masters Business Admin |
Statistik
International
Schweden | 6 |
Vereinigtes Königreich | 2 |
Operativ
Director of Finance/CFO | 2 |
Sales & Marketing | 1 |
Corporate Secretary | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
OSSDSIGN AB | Health Technology |
MODUS THERAPEUTICS HOLDING AB | Health Technology |
Private Unternehmen | 2 |
---|---|
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Health Technology |
ConvaTec (Sweden) AB |
- Börse
- Insiders
- Claes Lindblad
- Erfahrung